Total Payments
$4,882
2024 Payments
$703.90
Companies
48
Transactions
273
Medicare Patients
2,108
Medicare Billing
$193,515
Payment Breakdown by Category
Food & Beverage$4,585 (93.9%)
Education$296.84 (6.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,585 | 269 | 93.9% |
| Education | $296.84 | 4 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,261 | 81 | $0 (2024) |
| EMD Serono, Inc. | $494.11 | 40 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $330.28 | 9 | $0 (2024) |
| Biogen, Inc. | $272.68 | 15 | $0 (2024) |
| GENZYME CORPORATION | $200.79 | 5 | $0 (2020) |
| Genentech USA, Inc. | $168.81 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $162.30 | 13 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $155.23 | 9 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $139.31 | 7 | $0 (2019) |
| Banner Life Sciences, LLC | $112.68 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $703.90 | 25 | ABBVIE INC. ($284.92) |
| 2023 | $659.39 | 37 | ABBVIE INC. ($355.43) |
| 2022 | $881.86 | 47 | ABBVIE INC. ($339.01) |
| 2021 | $567.24 | 29 | AbbVie Inc. ($141.23) |
| 2020 | $197.43 | 10 | Kyowa Kirin, Inc. ($39.95) |
| 2019 | $459.33 | 37 | EMD Serono, Inc. ($167.87) |
| 2018 | $549.38 | 34 | EMD Serono, Inc. ($95.70) |
| 2017 | $863.40 | 54 | AbbVie, Inc. ($140.86) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: PAIN | ||||||
| 11/27/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Neurology | ||||||
| 10/31/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Neurology | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Neuroscience | ||||||
| 06/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 06/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 06/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Neuroscience | ||||||
| 03/28/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.27 | General |
| 02/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 413 | 528 | $91,094 | $36,065 |
| 2022 | 4 | 473 | 600 | $119,311 | $47,887 |
| 2021 | 9 | 591 | 659 | $151,830 | $58,188 |
| 2020 | 10 | 631 | 689 | $146,804 | $51,376 |
Total Patients
2,108
Total Services
2,476
Medicare Billing
$193,515
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 243 | 326 | $51,182 | $20,722 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 152 | $35,112 | $13,289 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 45 | 50 | $4,800 | $2,054 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 234 | 320 | $73,920 | $29,653 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 231 | $36,267 | $15,052 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,052 | $1,817 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 32 | $3,072 | $1,365 | 44.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 164 | 197 | $45,507 | $19,165 | 42.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 146 | 146 | $51,976 | $17,971 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 162 | 193 | $30,301 | $12,482 | 41.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $9,372 | $3,549 | 37.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 26 | 26 | $6,084 | $1,910 | 31.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 32 | 32 | $3,072 | $1,144 | 37.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 12 | $2,628 | $998.40 | 38.0% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Facility | 2021 | 16 | 17 | $1,700 | $534.99 | 31.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 14 | $1,190 | $433.02 | 36.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 123 | 123 | $43,788 | $15,610 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 165 | $38,115 | $12,351 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 204 | $32,028 | $11,170 | 34.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 22 | $9,372 | $3,651 | 39.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 36 | 36 | $8,424 | $2,917 | 34.6% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Facility | 2020 | 54 | 54 | $5,400 | $1,773 | 32.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 39 | 41 | $3,936 | $1,376 | 35.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 16 | $2,409 | $1,246 | 51.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 14 | $2,142 | $827.96 | 38.7% |
About Dr. Joseph Harris, M.D
Dr. Joseph Harris, M.D is a Neurology healthcare provider based in North Chesterfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023089760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Harris, M.D has received a total of $4,882 in payments from pharmaceutical and medical device companies, with $703.90 received in 2024. These payments were reported across 273 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($4,585).
As a Medicare-enrolled provider, Harris has provided services to 2,108 Medicare beneficiaries, totaling 2,476 services with total Medicare billing of $193,515. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location North Chesterfield, VA
- Active Since 01/31/2006
- Last Updated 01/27/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1023089760
Products in Payments
- QULIPTA (Drug) $692.41
- UBRELVY (Drug) $291.71
- Rebif (Biological) $276.11
- ULTOMIRIS (Biological) $220.16
- TYSABRI (Biological) $192.85
- ACTHAR (Biological) $187.81
- AUBAGIO (Drug) $159.55
- AIMOVIG (Biological) $146.72
- TROKENDI XR (Drug) $139.31
- OCREVUS (Biological) $122.65
- Zinbryta (Biological) $117.27
- BAFIERTAM (Drug) $112.68
- Mavenclad (Biological) $109.80
- DUOPA (Drug) $109.50
- EPIDIOLEX (Drug) $103.69
- SOLIRIS (Drug) $90.12
- UPLIZNA (Drug) $76.80
- Xeomin (Biological) $74.45
- NOURIANZ (Drug) $68.48
- Vimpat (Drug) $64.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.